Nuclear Medicine: Page 4

Plus Therapeutics inks AI deal with Ephemeral Technologies
By AuntMinnie.com staff writers
Plus Therapeutics is a clinical-stage pharmaceutical company developing radiopharmaceutical therapies for CNS cancers.
May 19, 2026
Digital handshake with blue data visualization and financial charts representing business partnership and technology integration
SNMMI highlights new radiopharmaceutical therapy
By AuntMinnie.com staff writers
Mice bearing PDAC xenografts received lutetium-177 (Lu-177) AKIR001, a radiopharmaceutical that targets CD44v6.
May 13, 2026
Scientific research figure showing tissue biodistribution bar charts and PET imaging scans of mouse with radiotracer uptake at different time points.
Eden Radioisotopes files NRC permit for isotope production complex
By AuntMinnie.com staff writers
The company said the facility is designed to produce up to 50% of global demand for molybdenum-99 (Mo-99).
May 6, 2026
Periodic table section showing Molybdenum, Technetium, and Manganese elements with atomic numbers and weights
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
By AuntMinnie.com staff writers
C-Ray Therapeutics has received active status from the FDA for its Type II Drug Master File for Cu-64 chloride for radiolabeling.
April 28, 2026
Hand pressing green keyboard key labeled FDA Food and Drug Administration
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
By AuntMinnie.com staff writers
TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.
April 22, 2026
Technician operating industrial equipment with yellow safety lighting in a control room environment
Ionetix raises $30M to scale radioisotope production
By AuntMinnie.com staff writers
The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.
April 21, 2026
Glowing atom symbol with orbiting electrons and bright nucleus in laboratory setting
Telix doses first patient in glioblastoma trial
By AuntMinnie.com staff writers
The patient was dosed at Austin Health in Melbourne, Australia.
April 15, 2026
Digital illustration of a human brain integrated with blue circuit board patterns and gold electronic pathways, representing artificial intelligence and technology.
Shine receives $263M conditional loan for Mo-99 isotope facility
By AuntMinnie.com staff writers
Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.
April 9, 2026
Modern industrial building with blue facade and white upper section under clear sky
First patients treated in RYZ401 radiopharmaceutical trial
By AuntMinnie.com staff writers
RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.
April 8, 2026
Glowing atom symbol with orange nucleus held in human hand against blue background
Consortium launches 5-year plan to improve theranostics outcomes
By Will Morton
The project aims to pave the way for personalized radiopharmaceutical therapy.
April 6, 2026
Glowing atom symbol with blue and orange energy effects over laboratory equipment background
SpectronRx raises $85M to expand radiopharmaceutical production
By AuntMinnie.com staff writers
The funding will support infrastructure investment at the company's Grissom Aeroplex campus in Indiana.
April 2, 2026
Stacked US dollar bills arranged in neat piles showing currency denominations
Cardinal Health expands Ac-225 production
By AuntMinnie.com staff writers
Since launching routine Ac-225 production at scale in late 2024, the company said it has quadrupled its weekly output.
April 1, 2026
Glowing atom symbol with blue and orange energy effects overlaid on laboratory equipment and industrial background
Previous Page
Page 4 of 445
Next Page